How I treat Logo
howitreat.in

A user-friendly, frequently updated reference guide that aligns with international guidelines and protocols.

Hereditary Spherocytosis and Other Membrane Abnormalities

Classification of protein abnormalities in the erythrocyte membrane that result in vertical or horizontal interaction defects and cause hemolytic anemia

  • Vertical interaction defects (Produces spherocytic anemia)
    • Primary spectrin deficiency
    • Secondary spectrin deficiency due to defects or deficiencies inProtein 4.2, Ankyrin and Band 3
  • Horizontal interaction defects (Produce elliptocytosis& other bizarre forms)
    • Actin
    • Protein 4.1
    • Adductin

 

Hereditary Spherocytosis

Introduction:

  • Hereditary spherocytosis is an autosomal dominant condition, occurring due to defect in vertical interaction.

 

Epidemiology:

  • Highest prevalence is seen in north European population (1 in 2000 births)

 

Etio-pathogenesis:

Deficiency of spectrin, ankyrin, band 3, protein 4.2 etc.

Reduced membrane stability and spontaneous loss of cell membranedue to rapid vesciculation

Reduction of cell surface to volume ratio

RBC is forced to assume smallest possible diameter for a given volume i.e. sphere.

As spherocytes have reduced flexibility, they are trapped in splenic sinusoids

Extravascularhemolysis

(Complete absence of spectrin is not viable, so homozygous children are not found)

 

Classification:

 

Trait

Mild 

Moderate 

Severe 

Hemoglobin 

Normal 

11-15 

8-12 

6-8 

Reticulocyte % 

Normal 

3-6 

>6 

>10 

Bilirubin 

<1.7 

1.7-3.4 

>3.4 

>5.1 

Spectrin molecules per RBC 

100 

80-100 

50-80 

40-60 

Splenectomy 

Not required 

Usually not required 

Necessary during school age, before puberty 

Necessary at early age (Delay until 6 years if possible) 

 

Clinical Features:

  • Varying presentation- Asymptomatic to marked hemolysis leading to hydropsfetalis. Severity depends on extent of loss of spectrin. Severity is relatively uniform in a given family.
  • Anemia- usually 5-30 days after birth as functioning of spleen becomes mature only after birth. But diagnosis may be made at any age depending on severity.
  • Splenomegaly- mild to moderate
  • Gall stones
  • Acholuric jaundice- Jaundice with absence of bile in urine.
  • 2 types of crisis may be seen in hereditary spherocytosis
    • Hyperhemolytic crisis
      • Triggered by infection
      • Presents with fever, abdominal pain, Jaundice, hypotension and shock
    • Aplastic crisis
      • Triggered by parvovirus, trauma, surgery, pregnancy
      • Presents as sudden worsening anemia
  • Skin lesions- Ulcerations, gouty tophi, chronic leg dermatitis, (related to decreased RBC deformability)
  • Extramedullary erythropoiesis- Masses may form in spine, kidney etc
  • Poor growth, deformities of hands and skull
  • Predisposition to malignancy- MPN, myeloma etc
  • Iron overload- May be seen even in untransfused patients due to associated HFE mutation
  • Angioid streaks in optic fundi
  • VTE and pulmonary hypertension
  • Rare non-hematological manifestations:
    • Neuromuscular abnormalities (as ankyrin and spectrin are expressed in neural tissues)-slowly progressive spinocerebellar degenerative disease, spinal cord dysfunction, movement disorders, cardiomyopathy
    • Distal renal tubular acidosis is seen with defects with band 3.

 

Investigations:

  • Hemogram:
    • Hemoglobin content- Normal/decreased
    • High quality smears are needed as spherocytes may appear as artefacts
    • Spherocytes- Abnormally small in sized RBCs which have uniform shape and lack central 1/3rd of pallor
    • Polychromatophilic cells and nucleated RBCs may be seen.
    • Pincered erythrocytes are seen in Band 3 deficiency.
    • Spherocyticacanthocytes are seen in beta spectrin deficiency
    • Spherocytes and stomatocytes may be seen in Japanese protein 4.2 deficiency
    • WBC and platelets – Normal
    • MCV- Normal/decreased
    • MCH – Normal
    • MCHC – Increased (>36g/dL)- It is the only anemia where MCHC is increased. Laser based counters provide histograms with hyperdenseerythrocytes (MCHC >40) which detects all cases of HS. Hence it is a best screening tool.
    • RDW- <14%
    • HS ratio- MCHC/MCV- If more than 0.36, it indicates presence of HS.
  • Reticulocyte count- >8%
  • Osmotic fragility test
  • Increased fragility
  • Hemolysis is complete between 0.5-0.4% NaCl
  • Normal test does not rule out HS.
  • Osmotic gradient ektacytometry- Measures deformability of whole RBC
  • Serum bilirubin-Raised
  • Fecal urobilinogen- Raised
  • LDH – Raised
  • Haptoglobin-Decreased
  • DCT and ICT- Negative
  • Parental blood testing for HS
  • Autohemolysis test
    • It has value in differentiating various types of congenital nonspherocytic hemolytic anemias
    • It measures the degree of spontaneous hemolysis of blood incubated at 37o C
    • Degree of hemolysis depends on integrity of cell membrane & adequacy of cell enzymes involved in glycolysis.
    • Normal – 0.2 – 2% hemolysis after 24- 48 hours.
    • Abnormalities

Type

Observation

Seen in

Type I

2-6% autohemolysis, but significant correction when glucose is added

PNH and G6PD deficiency

Type II

8-44% hemolysis& glucose has no effect

Pyruvate kinase deficiency

Type – III

5-25% hemolysis at 24 hours & 75% at 48 hrs

If glucose is added before incubation hemolysis is significantly reduced

Hereditoryspherocytosis

 

  • Acidified glycerol lysis test
    • Glycerol slows down entry of water into cells in vitro.
    • The time taken for lysis to occur is a function of the osmotic resistance of the cells
    • Hereditoryspherocytosis cells lyses more rapidly than normal cells
    • Test is easier to perform than osmotic fragility test.
  • Sodium dodecylsulphatesolubilizedpolyacrylamide gel (SDS-PAGE) electrophoresis 
    • Used to quantify proteins in the membrane of RBCs 
    • This is the confirmatory test for HS.
    • Results are expressed as ratios of individual RBC membrane proteins to Band 3.
  • Flow cytometry:
    • Binding of eosin labeled maleimide (EMA binding test)
    • Cells deficient in band 3 fail to bind to EMA
    • Other conditions giving reduced fluorescence: South east asian ovalocytosis, Congenital dyserythropoietic anemia Type-II, Hereditary pyropoikilocytosis and Cryohydrocytosis
  • Identification of gene defects- Involves sequencing of relevant genes to identify mutations in them.

 

Treatment:

  • Transfuse PRBCs as and when required
  • Folic acid supplementation- Life long
  • Phototherapy +/- exchange transfusion for neonates presenting with severe jaundice
  • Splenectomy: 
    • Restores the life-span of red cells to normal and hence cures hemolysis&hyperbilirubinemia.
    • Should be done after 5 years of age except in patients with severe anemia
    • Dehydrated hereditary stomatocytosis is a contraindication for splenectomy, hence this must be ruled out.
    • Indications: 
      • Marked hemolysis requiring multiple transfusions
      • Growth retardation/ skeletal changes
      • Anemia induced end organ damage
      • Development of leg ulcers
      • Appearance of extramedullary hematopoietic tumors
    • Laporoscopic is more feasible and safe.
    • Cholecystectomy may be performed at the same time, if there is cholelithiasis

 

Hereditary Elliptocytosis

(Hereditary Ovalocytosis)

  • Autosomal dominant condition
  • Gene affected is closely related to Rh locus on chromosome 1
  • Classification

 

Type of HE

Hemolysis

Erythrocyte Shape

Common HE

Variable; minimal to severe

Elliptocytes

Spherocytic HE (hemolytic ovalocytosis)

Present

Spherocytes and fat elliptocytes

Southeast Asian ovalocytosis (Stomatocytic HE Melanesian ovalocytosis)

Mild or absent

Roundish elliptocytes that are also stomatocytic- Oval cells with 1-2 longitudinal slits

 

  • RBCs fail to recover their biconcave shape after they acquire elliptical shape in microcirculation where they are subjected to shear stress.
  • Defect involves horizontal membrane protein interactions
    • Actin
    • Protein 4.1
    • Adductin
    • Glycophorin C

 

Clinical features

  • 90% do not have hemolysis
  • Asymptomatic HE patients may experience hemolysis in association with infections, hypersplenism, Vitamin B12 deficiency or microangiopathic disorders.
  • Some can have chronic hemolysis

 

Investigations:

  • Hemogram
    • Hemoglobin- Usually >12g/dL
    • Prominent elliptocytosis>25% RBCs & usually >60%(<25% are seen with megaloblastic anemia and iron deficiency anemia)
    • Pseudoelliptocytes (Artifacts during smear preparation)- They are seen only near the tail. Long axis of all pseudo elliptocytes are parallel.
  • Reticulocyte count – Mild elevation – >4%
  • In hemolytic hereditary elliptocytosis, lab findings due to hemolysis are seen
  • Osmotic fragility test- Abnormal only in severe HE

 

Treatment

  • Splenectomy for hemolytic variant (Otherwise no treatment is needed)

 

Note: Elliptocytes are resistant to malarial infection due to abnormal rigidity of membrane

 

Hereditary Pyropoikilocytosis

  • Autosomal recessive
  • Presents in infancy as severe hemolytic anemia with extreme poikilocytosis
  • Cells fragment when heated to 45o-46 o C (Normal – 50 o C)
  • They disintegrate when incubated at 37 o C for more than 6 hours.

 

Mutant spectrin- Prevents self association of heterodimers of spectrins

Disruption of membrane skeletal lattice & Membrane cell destabilization

Erythrocyte fragmentation &poikilocytosis

  • Peripheral smear: Morphologic abnormalities of RBCs- Budding, fragments, microspherocytes, elliptocytestriangulocytes.
  • MCV – Decreased  (25-55fL)
  • Auto hemolysis- Increased and not corrected by glucose.

 

Hereditary Stomatocytosis

  • Autosomal dominant with defect in stomatin gene

 

Deficiency of band 7 protein (Abnormality in RBC lipids)

RBC membrane is abnormally permeable to both Na+ & K+

Net gain of sodium is greater than net loss of potassium

Over hydration of cells

Hydrocytes look like stomatocytes in dried a stained blood films

(Slit mouth like area of pallor)

Wet smear – Appear uniconcave& bowl shaped.

  • Usually asymptomatic, rarely cause hemolytic anemia
  • 4 variants depending on intracellular sodium concentration (Normal- 5-10 mmol/l)
    • OverhydratedHst- MCHC decreased- Na- >60mmol/L
    • Dehydrated Hst- MCHC increased- Na- 12-18mmol/L
    • Cryohydrocytosis (Temperature sensitive leak) - Na- 20-50 mmol/L
    • Pseudohyperkalemia- Na- Normal
  • Peripheral smear shows stomatocytes (10% to 50%), macrocytosis
  • Osmotic fragility- Increased
  • Autohemolysis- increased(Partially corrected by ATP & glucose)
  • Treatment:
    • Folate supplements
    • Splenectomy in selected cases- Should not be done in dehydrated variant as it associated with marked thrombotic tendencies.
  • Acquired causes of stomatocytosis
    • Acute alcoholism
    • Liver disease
    • Cardiovascular disease

 

Hereditary Xerocytosis

  • Autosomal dominant condition

Net loss of intracellular K+ exceeds the passive Na+ influx

Net Na+ gain

Dehydration of cells

Target cell/ contracted & speculated cell

MCHC Increased – after >37% cytoplasmic viscosity increases

Decreased cellular deformability

Trapping in spleen

  • Clinical features
    • Compensated hemolytic anemia- Jaundice, splenomegaly, gall stones
    • Sometimes- Recurrent fetal losses, hydropsfetalis, neonatal hepatitis, familial pseudo-hyperkalemia
  • Treatment
    • Folate supplementation
    • No benefit of splenectomy

 

Infantile Pyknocytosis

  • Preterm infants presenting with transient hemolytic anemia (at 6-9 months of age) reticulocytosis and hyperbilirubinemia
  • Peripheral smear- Pyknocytes- Distorted, densely stained RBCs
  • Transfused RBCs also may become distorted
  • No intervention needed

 

Rh Deficiency Syndrome

  • Absence of Rh AG complex including Rh, RHAG, LW, Glycophorin beta, CD47 and protein 4.2
  • Present with mild to moderate hemolytic anemia
  • Peripheral smear- Stomatocytes, occasional spherocytes
  • Treatment- Splenectomy- if hemolysis is severe.

 

Familial deficiency of HDL

  • Accumulation of cholesterol in various tissues
  • Large orange tonsils
  • Hepatosplenomegaly
  • Hemolytic anemia with stomatocytosis

 

Sitosterolemia (Phytosterolemia)

  • Autosomal recessive
  • Mutations in transporters- ABCG5 or ABCG8 leading to increased absorption of plant sterols
  • Plasma levels of plant sterols is increased
  • Diagnosis confirmed by genetic tests
  • Clinical features:
    • Extreme phenotypic heterogeneity
    • Xanthomatosis
    • Early onset premature cardiovascular disease
    • Hemolytic anemia with stomatocytosis, macrothrombocytopenia, splenomegaly and abnormal bleeding
    • Splenomegaly
  • Treatment
    • Avoid diet rich in plant based fats
    • Bile acid sequestrants: Cholestyramine
    • Ezetimibe (selective cholesterol absorption inhibitor) - 10mg/day
    • No use of statins as HMG CoA reductase activity is already inhibited
    • Splenectomy if there is persistent anemia

 

Lecithin Cholesterol AcylTransferase Deficiency

  • Catalyses transfer of fatty acids from phosphotidylcholine to cholesterol
  • Autosomal dominant
  • Features include
    • Hyperlipidemia
    • Premature atherosclerosis
    • Corneal opacities
    • Chronic nephritis
    • Proteinuria
    • Mild anemia due to mild hemolysis
  • Target cells are seen in peripheral smear

 

Abnormalities of Membrane Lipids

Acanthocytosis/ Spur cell anemia

  • Spur cells are formed in severe liver disease
  • They undergo lysis in spleen as they are less deformable
  • Present with progressive hemolytic anemia, splenomegaly, hepatic derangement
  • Peripheral smear- RBCs show prominent, regular projection from surface.
  • They are formed when the outer lipid layer of the membrane acquires additional lipid
  • Splenectomy is potentially dangerous procedure in critically ill patients, hence is not recommended.
  • Differential diagnosis- Zieves syndrome- Hyperlipoproteinemia, jaundice, spherocytic hemolytic anemia in alcoholic patients with liver disease

 

Abetalipoproteinemia

  • Autosomal recessive

Defect in apolipoprotien B gene.

Failure to synthesize/ secrete apolipoprotein

No triglycerrides carried from intestines

Decreased plasma triglyceride, cholesterol and phospholipid levels

Increased sphingomyelin in outer membrane of RBCs

Formation of acanthocytes/ burr cells

 

  • It is often associated with
    • Mild hemolysis
    • Retinitis pigmentosa
    • Progressive ataxic neurological disease with intentional tremors
    • Fat malabsorption- Steatorrhea at 1 month of life
    • Hepatic Encephalpathy
  • Investigations:
    • Peripheral smear:Acanthocytes are seen, Increased nucleated RBCs
    • Reticulocytes are increased and they have normal shape
    • Intestinal biopsy: Engorged mucosal cells with lipid droplets
  • Treatment
    • Dietary restriction of triglycerrides
    • Supplement high doses of Vitamin A, D, E and K

 

Other neuro-acanthosis syndromes:

  • Chorea acanthosis syndrome:
    • Autosomal recessive
    • Normolipoproteinemicacanthosis
    • Neurological features include:
      • Progressive orofacialdyskinesis with tics, limb chorea, lip and tongue biting
      • Neurologic muscle hypotonia and atrophy
      • Absent or diminished reflexes
    • Increased CPK
    • MRI- Abnormalities of putamen and head of caudate
    • No anemia as RBC survival is mildly decreased
    • Mechanism of acathocyte formation is not clearly known
  • McLeod Phenotype
    • Acanthosis together with decreased expression of Kell antigen
    • Defective gene on Xp 21(Close to genes of Duchene muscular dystrophy and retinitis pigmentosa)
    • Gene codes for Kx protein that carries Kell blood group protein 
    • Mild compensated hemolytic anemia
    • May be associated with chronic granulomatous disease
    • Often have myopathy/ chorea
  • Huntington disease like 2
    • Mutations in junctophilin-3
    • Associated with tics, parkinsonism, motor neuron disease
  • Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome)
    • Progressive dementia, dystonia, spasticity, pallidial and retinal degeneration
    • Allelic variant- HARP syndrome
    • Hypobetalipoproteinemia
    • Acanthosis
    • Retinitis pigmentosa
    • Pallidal degeneration
    • Both are due to mutations in pantothenate kinase-2 gene

 

Figures:

Figure 8.19.1.jpg

Figure 8.19.1- Hereditary spherocytosis- Peripheral smear

 

Figure 8.19.2.jpg

Figure 8.19.2- Hereditary elliptocytosis- Peripheral smear

 

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Home

About Us

Support Us

An Initiative of

Veenadhare Edutech Private Limited

1299, 2nd Floor, Shanta Nivas,

Beside Hotel Swan Inn, Off J.M.Road, Shivajinagar

Pune - 411005

Maharashtra – India

How I treat Logo
howitreat.in

CIN: U85190PN2022PTC210569

Email: admin@howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.